Release 5
WorkflowThis page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions 
. Page versions: R5 R4B R4 R3
| Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: No defined compartments |
Raw Turtle (+ also see Turtle/RDF Format Specification)
Chemotherapy Regimen
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
[a fhir:PlanDefinition ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "KDN5"] ; #
fhir:text [
fhir:status [ fhir:v "additional" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n \n <table style=\"width: 100%;\">\n \n <tr>\n \n <td>\n \n \n <div style=\"width: 200px; height: 100px; vertical-align: top;\">National Comprehensive Cancer Network</div>\n \n </td>\n \n <td>\n \n <h3>Chemotherapy Order Template</h3>\n \n <h1>Kidney Cancer</h1>\n \n <h2>Gemcitabine/CARBOplatin</h2>\n \n </td>\n \n <td style=\"text-align: right; vertical-align: top;\">KDN5</td>\n \n </tr>\n \n </table>\n \n <table style=\"width: 100%; border-top: 1px solid; border-bottom: 1px solid;\">\n \n <tr>\n \n <td style=\"width: 33%; border-right: 1px solid; vertical-align: top\">\n \n <h4>INDICATION:</h4>\n \n <p>Metastatic or Relapsed – Collecting Duct/Medullary Subtypes</p>\n \n </td>\n \n <td style=\"width: 34%; border-right: 1px solid; vertical-align: top\">\n \n <h4>REFERENCES:</h4>\n \n <ol>\n \n <li>\n <a href=\"http://www.example.org/professionals/physician_gls/PDF/kidney.pdf\">NCCN Guidelines® for Kidney Cancer. V.3.2015.</a>\n </li>\n \n <li>\n <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?term=%22The+Journal+of+urology%22%5BJour%5D+AND+1698%5Bpage%5D+AND+2007%5Bpdat%5D+AND+Oudard+S%5Bauthor%5D\">Oudard S, et al. \n <em>J Urol</em>. 2007;177(5):1698-702.\n </a>\n <sup>\n \n <a href=\"http://www.example.org/OrderTemplates/PDF/appendix_E.pdf\">a</a>\n </sup>\n \n </li>\n \n </ol>\n \n </td>\n \n <td style=\"width: 33%; vertical-align: top\">\n \n <h4>NCCN SUPPORTIVE CARE:</h4>\n \n <ol>\n \n <li>\n \n <i>Emetic Risk:</i>\n \n <table>\n \n <tr>\n \n <td>Day 1</td>\n \n <td>Moderate</td>\n \n </tr>\n \n <tr>\n \n <td>Day 8</td>\n \n <td>Low</td>\n \n </tr>\n \n </table>\n \n </li>\n \n <li>\n \n <i>Fever Neutropenia Risk:</i>\n <br/>\n Refer to \n <a href=\"http://www.example.org/professionals/physician_gls/PDF/myeloid_growth.pdf\">NCCN Guidelines for Myeloid Growth Factors. V.2.2014</a>\n \n </li>\n \n </ol>\n \n </td>\n \n </tr>\n \n </table>\n \n \n <h4>CHEMOTHERAPY REGIMEN</h4>\n \n <p>\n \n <i>21-day cycle for 6 cycles</i>\n \n </p>\n \n <ul>\n \n <li>Gemcitabine 1250 mg/m\n <sup>2</sup> IV over 30 minutes on Days 1 and 8\n </li>\n \n <li>CARBOplatin AUC 5 IV over 30 minutes on Day 1</li>\n \n </ul>\n \n </div>"
] ; #
fhir:contained ( [
a fhir:ActivityDefinition ;
fhir:id [ fhir:v "1111" ] ;
fhir:status [ fhir:v "draft" ] ;
fhir:product [
a fhir:CodeableConcept ;
fhir:coding ( [
fhir:system [ fhir:v "http://www.nlm.nih.gov/research/umls/rxnorm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "12574" ] ;
fhir:display [ fhir:v "gemcitabine" ]
] ) ;
fhir:text [ fhir:v "gemcitabine" ]
] ;
fhir:dosage ( [
fhir:text [ fhir:v "1250 mg/m² IV over 30 minutes" ] ;
fhir:timing [
fhir:repeat [
fhir:duration [ fhir:v "30"^^xsd:decimal ] ;
fhir:durationUnit [ fhir:v "min" ]
]
] ;
fhir:route [
fhir:text [ fhir:v "IV" ]
] ;
fhir:doseAndRate ( [
fhir:type [
fhir:coding ( [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/dose-rate-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "ordered" ] ;
fhir:display [ fhir:v "Ordered" ]
] )
] ;
fhir:dose [
a fhir:Quantity ;
fhir:value [ fhir:v "1250"^^xsd:decimal ] ;
fhir:unit [ fhir:v "mg/m²" ]
]
] )
] )
] [
a fhir:ActivityDefinition ;
fhir:id [ fhir:v "2222" ] ;
fhir:status [ fhir:v "draft" ] ;
fhir:product [
a fhir:CodeableConcept ;
fhir:coding ( [
fhir:system [ fhir:v "http://www.nlm.nih.gov/research/umls/rxnorm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "40048" ] ;
fhir:display [ fhir:v "Carboplatin" ]
] ) ;
fhir:text [ fhir:v "CARBOplatin" ]
] ;
fhir:dosage ( [
fhir:text [ fhir:v "AUC 5 IV over 30 minutes" ] ;
fhir:timing [
fhir:repeat [
fhir:duration [ fhir:v "30"^^xsd:decimal ] ;
fhir:durationUnit [ fhir:v "min" ]
]
] ;
fhir:route [
fhir:text [ fhir:v "IV" ]
] ;
fhir:doseAndRate ( [
fhir:type [
fhir:coding ( [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/dose-rate-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "ordered" ] ;
fhir:display [ fhir:v "Ordered" ]
] )
] ;
fhir:dose [
a fhir:Quantity ;
fhir:extension ( [
fhir:url [ fhir:v "http://example.org/fhir/AUC-dose"^^xsd:anyURI ] ;
fhir:value [ fhir:v "5"^^xsd:integer ]
] )
]
] )
] )
] ) ; #
fhir:identifier ( [
fhir:system [ fhir:v "http://example.org/ordertemplates"^^xsd:anyURI ] ;
fhir:value [ fhir:v "KDN5" ]
] ) ; #
fhir:version [ fhir:v "1"] ; #
fhir:name [ fhir:v "GemcitabineCARBOplatin"] ; #
fhir:title [ fhir:v "Gemcitabine/CARBOplatin"] ; #
fhir:type [
fhir:text [ fhir:v "Chemotherapy Order Template" ]
] ; #
fhir:status [ fhir:v "draft"] ; #
fhir:experimental [ fhir:v "true"^^xsd:boolean] ; #
fhir:publisher [ fhir:v "National Comprehensive Cancer Network, Inc."] ; #
fhir:description [ fhir:v "Gemcitabine/CARBOplatin"] ; #
fhir:useContext ( [
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/usagecontext-group"^^xsd:anyURI ] ;
fhir:value [ fhir:v "A" ]
] ) ;
fhir:code [
fhir:system [ fhir:v "http://example.org/fhir/CodeSystem/indications"^^xsd:anyURI ] ;
fhir:code [ fhir:v "treamentSetting-or-diseaseStatus" ]
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:text [ fhir:v "Metastatic" ]
]
] [
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/usagecontext-group"^^xsd:anyURI ] ;
fhir:value [ fhir:v "A" ]
] ) ;
fhir:code [
fhir:system [ fhir:v "http://example.org/fhir/CodeSystem/indications"^^xsd:anyURI ] ;
fhir:code [ fhir:v "disease-or-histology" ]
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:text [ fhir:v "Collecting Duct/Medullary Subtypes" ]
]
] [
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/usagecontext-group"^^xsd:anyURI ] ;
fhir:value [ fhir:v "A" ]
] ) ;
fhir:code [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/usage-context-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "focus" ]
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:text [ fhir:v "Kidney Cancer" ]
]
] [
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/usagecontext-group"^^xsd:anyURI ] ;
fhir:value [ fhir:v "B" ]
] ) ;
fhir:code [
fhir:system [ fhir:v "http://example.org/fhir/CodeSystem/indications"^^xsd:anyURI ] ;
fhir:code [ fhir:v "treatmentSetting-or-diseaseStatus" ]
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:text [ fhir:v "Relapsed" ]
]
] [
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/usagecontext-group"^^xsd:anyURI ] ;
fhir:value [ fhir:v "B" ]
] ) ;
fhir:code [
fhir:system [ fhir:v "http://example.org/fhir/CodeSystem/indications"^^xsd:anyURI ] ;
fhir:code [ fhir:v "disease-or-histology" ]
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:text [ fhir:v "Collecting Duct/Medullary Subtypes" ]
]
] [
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/usagecontext-group"^^xsd:anyURI ] ;
fhir:value [ fhir:v "B" ]
] ) ;
fhir:code [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/usage-context-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "focus" ]
] ;
fhir:value [
a fhir:CodeableConcept ;
fhir:text [ fhir:v "Kidney Cancer – Collecting Duct/Medullary Subtypes - Metastatic" ]
]
] ) ; #
fhir:copyright [ fhir:v "All rights reserved."] ; #
fhir:approvalDate [ fhir:v "2016-07-27"^^xsd:date] ; #
fhir:lastReviewDate [ fhir:v "2016-07-27"^^xsd:date] ; #
fhir:author ( [
fhir:name [ fhir:v "Lee Surprenant" ]
] ) ; #
fhir:relatedArtifact ( [
fhir:type [ fhir:v "derived-from" ] ;
fhir:display [ fhir:v "NCCN Guidelines for Kidney Cancer. V.2.2016" ] ;
fhir:document [
fhir:url [ fhir:v "http://www.example.org/professionals/physician_gls/PDF/kidney.pdf"^^xsd:anyURI ]
]
] [
fhir:type [
fhir:v "citation" ;
fhir:extension ( [
fhir:url [ fhir:v "http://example.org/fhir/regimenReferenceType"^^xsd:anyURI ] ;
fhir:value [ fhir:v "a" ]
] )
] ;
fhir:citation [ fhir:v "Oudard S, et al. J Urol. 2007;177(5):1698-702" ] ;
fhir:document [
fhir:url [ fhir:v "http://www.ncbi.nlm.nih.gov/pubmed/17437788"^^xsd:anyURI ]
]
] ) ; #
fhir:action ( [
fhir:selectionBehavior [ fhir:v "exactly-one" ] ;
fhir:action ( [
fhir:selectionBehavior [ fhir:v "all" ] ;
fhir:action ( [
fhir:groupingBehavior [ fhir:v "sentence-group" ] ;
fhir:selectionBehavior [ fhir:v "exactly-one" ] ;
fhir:action ( [
fhir:id [ fhir:v "cycle-definition-1" ] ;
fhir:textEquivalent [ fhir:v "21-day cycle for 6 cycles" ] ;
fhir:timing [
a fhir:Timing ;
fhir:repeat [
fhir:count [ fhir:v "6"^^xsd:positiveInteger ] ;
fhir:duration [ fhir:v "21"^^xsd:decimal ] ;
fhir:durationUnit [ fhir:v "d" ]
]
] ;
fhir:action ( [
fhir:id [ fhir:v "action-1" ] ;
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"^^xsd:anyURI ] ;
fhir:extension ( [
fhir:url [ fhir:v "day"^^xsd:anyURI ] ;
fhir:value [ fhir:v "1"^^xsd:integer ]
] [
fhir:url [ fhir:v "day"^^xsd:anyURI ] ;
fhir:value [ fhir:v "8"^^xsd:integer ]
] )
] ) ;
fhir:textEquivalent [ fhir:v "Gemcitabine 1250 mg/m² IV over 30 minutes on days 1 and 8" ] ;
fhir:definition [ fhir:v "#1111"^^xsd:anyURI ]
] [
fhir:id [ fhir:v "action-2" ] ;
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle"^^xsd:anyURI ] ;
fhir:extension ( [
fhir:url [ fhir:v "day"^^xsd:anyURI ] ;
fhir:value [ fhir:v "1"^^xsd:integer ]
] )
] ) ;
fhir:textEquivalent [ fhir:v "CARBOplatin AUC 5 IV over 30 minutes on Day 1" ] ;
fhir:relatedAction ( [
fhir:targetId [ fhir:v "action-1" ] ;
fhir:relationship [ fhir:v "concurrent-with-start" ]
] ) ;
fhir:definition [ fhir:v "#2222"^^xsd:anyURI ]
] )
] )
] )
] )
] )] . #
# -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 hl7.fhir.core#5.0.0 generated on Sun, Mar 26, 2023 15:25+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4 |
Compare to R4B |
|
Propose a change